NTT Venture Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Anumanaanumana.aiin𝕏Nov 2022
Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making.
AI & Machine LearningBiotechDigital HealthMedical DevicesCambridge, US
Murali Aravamudan(Executive Officer, Director)Harris Fishman(Executive Officer)Alan Colowick(Director)Cheranjit Rihal(Director)David Goel(Director)Kyle Bettigole(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.